VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $12,188,000 | -30.9% | 119,900 | +55.3% | 0.31% | -29.8% |
| Q3 2015 | $17,638,000 | +2.8% | 77,200 | 0.0% | 0.45% | -0.2% |
| Q2 2015 | $17,150,000 | -5.8% | 77,200 | -15.8% | 0.45% | +1.6% |
| Q1 2015 | $18,213,000 | +11.7% | 91,700 | -26.2% | 0.44% | +10.0% |
| Q4 2014 | $16,308,000 | +44.7% | 124,300 | +44.7% | 0.40% | +65.7% |
| Q3 2014 | $11,270,000 | +4.0% | 85,900 | 0.0% | 0.24% | +7.6% |
| Q2 2014 | $10,834,000 | +103.9% | 85,900 | +113.2% | 0.22% | +95.7% |
| Q1 2014 | $5,313,000 | – | 40,300 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |